First human trial launches for new CMV vaccine candidate
⭐️ VACCINE ⭐️
Completed
This study was the first time a new vaccine candidate for cytomegalovirus (CMV) was tested in people. Researchers gave the vaccine, called SPYVLP01, to 120 healthy adults to check if it was safe and if it triggered an immune response. The main goal was to monitor for side effects…
Phase: PHASE1 • Sponsor: SpyBiotech Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 20, 2026 14:48 UTC